NO20002945D0 - Stabiliserte teriparatidoppløsninger - Google Patents

Stabiliserte teriparatidoppløsninger

Info

Publication number: NO20002945D0
Authority: NO; Norway
Prior art keywords: stabilized teriparatide; solutions; teriparatide solutions; stabilized; teriparatide
Prior art date: 1997-12-09

Application number

NO20002945A

Other languages

English (en)

Other versions

NO327302B1 (no

NO20002945L (no

Inventor

Chin-Ming Chang

Henry Acken Havel

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-09

Filing date

2000-06-08

Publication date

2000-06-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22086574&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20002945(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-06-08 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2000-06-08 Publication of NO20002945D0 publication Critical patent/NO20002945D0/no

2000-07-07 Publication of NO20002945L publication Critical patent/NO20002945L/no

2009-06-02 Publication of NO327302B1 publication Critical patent/NO327302B1/no

Links

108010049264 Teriparatide Proteins 0.000 title 1
OGBMKVWORPGQRR-UMXFMPSGSA-N teriparatide Chemical compound C([C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CNC=N1 OGBMKVWORPGQRR-UMXFMPSGSA-N 0.000 title 1
229960005460 teriparatide Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Zoology (AREA)
Rheumatology (AREA)
Immunology (AREA)
Dermatology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Silver Salt Photography Or Processing Solution Therefor (AREA)

NO20002945A 1997-12-09 2000-06-08 Lagringsstabil sammensetning, forseglet ror eller patron inneholdende nevnte sammensetning samt fremgangsmate for deres fremstilling NO327302B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6907597P	1997-12-09	1997-12-09
PCT/US1998/026043 WO1999029337A1 (en)	1997-12-09	1998-12-08	Stabilized teriparatide solutions

Publications (3)

Publication Number	Publication Date
NO20002945D0 true NO20002945D0 (no)	2000-06-08
NO20002945L NO20002945L (no)	2000-07-07
NO327302B1 NO327302B1 (no)	2009-06-02

Family

ID=22086574

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20002945A NO327302B1 (no)	1997-12-09	2000-06-08	Lagringsstabil sammensetning, forseglet ror eller patron inneholdende nevnte sammensetning samt fremgangsmate for deres fremstilling

Country Status (31)

Country	Link
EP (2)	EP0920873B1 (no)
JP (1)	JP4405666B2 (no)
KR (1)	KR100482703B1 (no)
CN (1)	CN1198644C (no)
AR (1)	AR018526A1 (no)
AT (1)	ATE260113T1 (no)
AU (1)	AU759726B2 (no)
BR (1)	BR9813463A (no)
CA (1)	CA2314313C (no)
CY (1)	CY1114000T1 (no)
CZ (1)	CZ302401B6 (no)
DE (1)	DE69821872T2 (no)
DK (2)	DK1417972T4 (no)
EA (1)	EA004761B1 (no)
EG (1)	EG23675A (no)
ES (2)	ES2215268T3 (no)
HU (1)	HU230784B1 (no)
ID (1)	ID27741A (no)
IL (1)	IL136662A (no)
MY (1)	MY120063A (no)
NO (1)	NO327302B1 (no)
NZ (1)	NZ505222A (no)
PE (1)	PE20000001A1 (no)
PL (1)	PL194268B1 (no)
PT (2)	PT920873E (no)
SK (1)	SK288203B6 (no)
TR (1)	TR200002134T2 (no)
TW (1)	TW570811B (no)
UA (1)	UA72884C2 (no)
WO (1)	WO1999029337A1 (no)
ZA (1)	ZA9811127B (no)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20010083126A (ko) *	1998-07-23	2001-08-31	피터 지. 스트링거	여포자극 호르몬 및 여포자극 호르몬 변이체 제형, 제품및 방법
US20030166525A1 (en)	1998-07-23	2003-09-04	Hoffmann James Arthur	FSH Formulation
AR033639A1 (es)	1998-08-19	2004-01-07	Lilly Co Eli	Uso de hormonas paratiroideas para preparar medicamentos para reducir el riesgo de fracturas oseas vertebrales o no vertebrales en seres humanos con riesgo de padecer o que padecen osteoporosis
US7022674B2 (en)	1999-12-16	2006-04-04	Eli Lilly And Company	Polypeptide compositions with improved stability
US20020061838A1 (en) *	2000-05-17	2002-05-23	Barton Holmquist	Peptide pharmaceutical formulations
AU785444B2 (en) *	2000-05-19	2007-06-14	Jefferson Pharmaceuticals, Llc	Peptide pharmaceutical formulations
US7087248B2 (en) *	2000-06-30	2006-08-08	Daiichi Asubio Pharma Co., Ltd.	Pharmaceutical component based on human parathyroid hormone and a pharmaceutical composition for intranasal administration comprising the component
EP1391209A4 (en) *	2001-05-30	2009-12-16	Chugai Pharmaceutical Co Ltd	PROTEIN PREPARATION
AU2002363412A1 (en) *	2001-11-05	2003-05-19	Eli Lilly And Company	Method for improving stability of a bone-connecting implant
EP1767213A3 (en) *	2001-11-05	2007-04-25	Eli Lilly & Company	Method for improving stability of a bone-connecting implant
US8088734B2 (en)	2003-01-21	2012-01-03	Unigene Laboratories Inc.	Oral delivery of peptides
MXPA05010635A (es)	2003-04-02	2005-12-12	Ares Trading Sa	Formulaciones farmaceuticas liquidas de hormona estimulante de foliculos y hormona luteinizante junto con un surfactante no ionico.
WO2004112826A1 (en)	2003-06-20	2004-12-29	Ares Trading Sa	Freeze-dried fsh / lh formulations
CA2535156A1 (en)	2003-08-08	2005-02-24	Abgenix, Inc.	Antibodies directed to parathyroid hormone (pth) and uses thereof
US7318925B2 (en)	2003-08-08	2008-01-15	Amgen Fremont, Inc.	Methods of use for antibodies against parathyroid hormone
US7329725B1 (en)	2003-10-29	2008-02-12	Nastech Pharmaceutical Company Inc.	Phage displayed Trp cage ligands
DK3300721T4 (da)	2003-11-20	2025-03-03	Novo Nordisk As	Propylenglycol-holdige peptidformuleringer hvilke er optimale til fremstilling og til anvendelse i injektionsindretninger
EP2492261B1 (en)	2003-12-23	2015-02-18	Infinity Discovery, Inc.	Analogs of benzoquinone-containing ansamycins for the treatment of cancer
US8268791B2 (en)	2004-08-25	2012-09-18	Aegis Therapeutics, Llc.	Alkylglycoside compositions for drug administration
US9114069B2 (en)	2004-08-25	2015-08-25	Aegis Therapeutics, Llc	Antibacterial compositions for drug administration
US9895444B2 (en)	2004-08-25	2018-02-20	Aegis Therapeutics, Llc	Compositions for drug administration
US20060046962A1 (en)	2004-08-25	2006-03-02	Aegis Therapeutics Llc	Absorption enhancers for drug administration
US8642564B2 (en)	2004-08-25	2014-02-04	Aegis Therapeutics, Llc	Compositions for drug administration
WO2006025882A2 (en) *	2004-08-25	2006-03-09	The Uab Research Foundation	Absorption enhancers for drug administration
US20140162965A1 (en)	2004-08-25	2014-06-12	Aegis Therapeutics, Inc.	Compositions for oral drug administration
KR100700869B1 (ko) *	2005-06-03	2007-03-29	재단법인 목암생명공학연구소	Ｐｔｈ, 완충제 및 안정제를 포함하는 안정한 ｐｔｈ조성물
CN101355959B (zh)	2005-11-10	2013-02-27	密歇根理工大学管理委员会	黑熊甲状旁腺素和使用黑熊甲状旁腺素的方法
US8226949B2 (en)	2006-06-23	2012-07-24	Aegis Therapeutics Llc	Stabilizing alkylglycoside compositions and methods thereof
US7803770B2 (en)	2006-10-03	2010-09-28	Radius Health, Inc.	Method of treating osteoporosis comprising administration of PTHrP analog
USRE49444E1 (en)	2006-10-03	2023-03-07	Radius Health, Inc.	Method of treating osteoporosis comprising administration of PTHrP analog
EP2073789B8 (en) *	2006-10-03	2023-02-08	Radius Health, Inc.	A stable composition comprising a bone anabolic protein, namely a pthrp analogue, and uses thereof
EP1958618A1 (de)	2007-02-15	2008-08-20	Octapharma AG	Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren
BRPI0810835A2 (pt) *	2007-04-12	2015-06-16	Infinity Discovery Inc	Formulações de hidroquinona ansamicina
WO2008150929A1 (en) *	2007-05-29	2008-12-11	Manhattan Pharmaceuticals, Inc.	Topical compositions comprising a macromolecule and methods of using same
WO2009002521A2 (en)	2007-06-25	2008-12-31	Amgen Inc.	Compositions of specific binding agents to hepatocyte growth factor
ES2586032T3 (es)	2008-03-28	2016-10-11	Hale Biopharma Ventures, Llc	Administración de composiciones de benzodiazepinas
AU2009305755B2 (en)	2008-10-15	2014-09-18	Infinity Pharmaceuticals, Inc.	Ansamycin hydroquinone compositions
US8440631B2 (en)	2008-12-22	2013-05-14	Aegis Therapeutics, Llc	Compositions for drug administration
ES2663322T3 (es) *	2009-09-09	2018-04-12	Asahi Kasei Pharma Corporation	Agente terapéutico/profiláctico que contiene PTH para la osteoporosis, caracterizado porque la PTH se administra una vez por semana en una dosis unitaria de 200 unidades
CA2782640A1 (en)	2009-12-07	2011-06-16	Michigan Technological University	Black bear parathyroid hormone and methods of using black bear parathyroid hormone
CN103796656A (zh)	2011-06-14	2014-05-14	哈尔生物药投资有限责任公司	苯二氮卓的投与
CN102731643A (zh) *	2012-06-26	2012-10-17	深圳翰宇药业股份有限公司	一种治疗骨质疏松多肽的制备方法
CN103301058A (zh) *	2013-06-17	2013-09-18	深圳翰宇药业股份有限公司	一种特立帕肽注射用组合物及其制备方法和制剂
MX393599B (es)	2015-04-29	2025-03-19	Radius Pharmaceuticals Inc	Rad1901 para usarse en el tratamiento de cancer en sujetos con cancer positivo a receptor de estrogeno alfa resistente a farmaco
CN106309358A (zh) *	2015-06-29	2017-01-11	成都金凯生物技术有限公司	含有人甲状旁腺激素的药物组合物及其制备方法与用途
JP6634758B2 (ja) *	2015-09-25	2020-01-22	ニプロ株式会社	液体組成物及び凍結乾燥製剤
SMT202400423T1 (it)	2016-03-01	2024-11-15	Ascendis Pharma Bone Diseases As	Profarmaci di pth
SMT202300124T1 (it)	2016-09-29	2023-05-12	Ascendis Pharma Bone Diseases As	Composti pth con bassi rapporti picco/valle
HUE070273T2 (hu)	2016-09-29	2025-05-28	Ascendis Pharma Bone Diseases As	Szabályozott hatóanyag-leadású PTH vegyületek
HUE063235T2 (hu)	2016-09-29	2024-01-28	Ascendis Pharma Bone Diseases As	Adagolási rendszer szabályozott leadású PTH vegyülethez
DK3565542T3 (da)	2017-01-05	2024-07-01	Radius Pharmaceuticals Inc	Polymorphic forms of rad1901-2hcl
US10996208B2 (en)	2017-04-28	2021-05-04	Radius Health, Inc.	Abaloparatide formulations and methods of testing, storing, modifying, and using same
TWI847306B (zh)	2017-08-24	2024-07-01	丹麥商諾佛儂迪克股份有限公司	Ｇｌｐ-１組成物及其用途
CA3075984C (en) *	2017-09-22	2024-10-01	Asahi Kasei Pharma Corporation	LIQUID PHARMACEUTICAL COMPOSITION CONTAINING TERIPARATIDE WITH EXCELLENT PHARMACOKINETIC AND/OR SAFETY PROPERTIES
JP2019060866A (ja) *	2017-09-22	2019-04-18	旭化成ファーマ株式会社	液状医薬組成物の体内動態を予測する方法
JP6577683B2 (ja) *	2017-09-22	2019-09-18	旭化成ファーマ株式会社	安定性に優れるテリパラチド含有液状医薬組成物
CN108159404B (zh) *	2018-01-05	2019-08-27	北京博康健基因科技有限公司	重组人甲状旁腺激素制剂及其制备方法
WO2019220654A1 (ja) *	2018-05-17	2019-11-21	旭化成ファーマ株式会社	Ｎ－ホルミルピぺリジン含有量が低減されている、及び／又は、凍結乾燥ケーキの崩潰又は収縮が抑制されている、製剤
WO2020165087A1 (en)	2019-02-11	2020-08-20	Ascendis Pharma Bone Diseases A/S	Liquid pharmaceutical formulations of pth conjugates
CN112439054B (zh) *	2019-08-28	2023-05-16	深圳翰宇药业股份有限公司	一种特立帕肽缓释凝胶注射液及其制备方法
BR112022013795A2 (pt)	2020-02-18	2022-09-13	Novo Nordisk As	Composição farmacêutica líquida, e, kit
WO2021195877A1 (en) *	2020-03-30	2021-10-07	Sichuan Luzhou Buchang Bio-Pharmaceutical Co., Ltd.	Formulations of human parathyroid hormone (pth) and methods for producing same
CN113967249A (zh) *	2021-12-10	2022-01-25	深圳先进技术研究院	甲状旁腺激素在制备治疗男性抑郁症的药物或保健品中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6360940A (ja) *	1986-09-01	1988-03-17	Toyo Jozo Co Ltd	白内障の予防または治療剤
JP2505812B2 (ja) *	1987-07-10	1996-06-12	旭化成工業株式会社	ｈ―ＰＴＨ（１―３４）凍結乾燥組成物
US5059587A (en) *	1987-08-03	1991-10-22	Toyo Jozo Company, Ltd.	Physiologically active peptide composition for nasal administration
DE3935738A1 (de) *	1989-10-27	1991-05-08	Forssmann Wolf Georg	Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff
GB9020544D0 (en) †	1990-09-20	1990-10-31	Sandoz Ltd	Improvements in or relating to organic compounds
DE69228828T2 (de) *	1991-12-09	1999-12-16	Asahi Chemical Ind	Stabilisierte parathormonzusammensetzung
DE69332105T2 (de)	1992-09-29	2003-03-06	Inhale Therapeutic Systems, San Carlos	Pulmonale abgabe von aktiven fragmenten des parathormons
IT1255723B (it) †	1992-10-09	1995-11-13		Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione
US5496801A (en) *	1993-12-23	1996-03-05	Allelix Biopharmaceuticals Inc.	Parathyroid hormone formulation
DE19538687A1 (de) †	1995-10-17	1997-04-24	Boehringer Mannheim Gmbh	Stabile pharmazeutische Darreichungsformen enthaltend Parathormon

1998
- 1998-12-04 ZA ZA9811127A patent/ZA9811127B/xx unknown
- 1998-12-04 MY MYPI98005507A patent/MY120063A/en unknown
- 1998-12-07 DK DK03104219.5T patent/DK1417972T4/en active
- 1998-12-07 DK DK98123225T patent/DK0920873T3/da active
- 1998-12-07 ES ES98123225T patent/ES2215268T3/es not_active Expired - Lifetime
- 1998-12-07 PT PT98123225T patent/PT920873E/pt unknown
- 1998-12-07 DE DE69821872T patent/DE69821872T2/de not_active Revoked
- 1998-12-07 EG EG151498A patent/EG23675A/xx active
- 1998-12-07 AR ARP980106213A patent/AR018526A1/es active IP Right Grant
- 1998-12-07 PT PT3104219T patent/PT1417972E/pt unknown
- 1998-12-07 EP EP98123225A patent/EP0920873B1/en not_active Revoked
- 1998-12-07 ES ES03104219T patent/ES2405994T5/es not_active Expired - Lifetime
- 1998-12-07 AT AT98123225T patent/ATE260113T1/de not_active IP Right Cessation
- 1998-12-07 EP EP03104219.5A patent/EP1417972B2/en not_active Expired - Lifetime
- 1998-12-08 JP JP2000524006A patent/JP4405666B2/ja not_active Expired - Lifetime
- 1998-12-08 EA EA200000629A patent/EA004761B1/ru not_active IP Right Cessation
- 1998-12-08 NZ NZ505222A patent/NZ505222A/en not_active IP Right Cessation
- 1998-12-08 BR BR9813463-9A patent/BR9813463A/pt not_active Application Discontinuation
- 1998-12-08 IL IL13666298A patent/IL136662A/en not_active IP Right Cessation
- 1998-12-08 AU AU17177/99A patent/AU759726B2/en not_active Expired
- 1998-12-08 TR TR2000/02134T patent/TR200002134T2/xx unknown
- 1998-12-08 ID IDW20001318A patent/ID27741A/id unknown
- 1998-12-08 HU HU0004447A patent/HU230784B1/hu unknown
- 1998-12-08 UA UA2000074034A patent/UA72884C2/uk unknown
- 1998-12-08 PL PL98340902A patent/PL194268B1/pl unknown
- 1998-12-08 SK SK1532-2000A patent/SK288203B6/sk not_active IP Right Cessation
- 1998-12-08 CN CNB988119641A patent/CN1198644C/zh not_active Ceased
- 1998-12-08 CZ CZ20002115A patent/CZ302401B6/cs not_active IP Right Cessation
- 1998-12-08 WO PCT/US1998/026043 patent/WO1999029337A1/en not_active Ceased
- 1998-12-08 KR KR10-2000-7006211A patent/KR100482703B1/ko not_active Expired - Lifetime
- 1998-12-08 CA CA002314313A patent/CA2314313C/en not_active Expired - Lifetime
- 1998-12-09 PE PE1998001200A patent/PE20000001A1/es not_active IP Right Cessation
- 1998-12-09 TW TW087120429A patent/TW570811B/zh not_active IP Right Cessation
2000
- 2000-06-08 NO NO20002945A patent/NO327302B1/no not_active IP Right Cessation
2013
- 2013-05-17 CY CY20131100405T patent/CY1114000T1/el unknown

Also Published As

Publication number	Publication date
WO1999029337A1 (en)	1999-06-17
NZ505222A (en)	2003-05-30
PE20000001A1 (es)	2000-01-17
AR018526A1 (es)	2001-11-28
DK0920873T3 (da)	2004-06-28
CZ302401B6 (cs)	2011-05-04
EA200000629A1 (ru)	2000-12-25
TR200002134T2 (tr)	2000-11-21
PT920873E (pt)	2004-06-30
CZ20002115A3 (en)	2001-05-16
UA72884C2 (uk)	2005-05-16
CN1281370A (zh)	2001-01-24
EP1417972B1 (en)	2013-04-10
EP0920873A3 (en)	1999-08-04
PL194268B1 (pl)	2007-05-31
IL136662A0 (en)	2001-06-14
HUP0004447A3 (en)	2003-06-30
JP2001525372A (ja)	2001-12-11
DE69821872T2 (de)	2005-01-05
NO327302B1 (no)	2009-06-02
SK15322000A3 (sk)	2001-05-10
EG23675A (en)	2007-04-15
PL340902A1 (en)	2001-03-12
EP1417972A1 (en)	2004-05-12
TW570811B (en)	2004-01-11
EP0920873B1 (en)	2004-02-25
NO20002945L (no)	2000-07-07
AU759726B2 (en)	2003-04-17
HK1021798A1 (en)	2000-07-07
DE69821872D1 (de)	2004-04-01
PT1417972E (pt)	2013-05-24
AU1717799A (en)	2005-05-16
CA2314313A1 (en)	1999-06-17
DK1417972T3 (da)	2013-05-13
ATE260113T1 (de)	2004-03-15
HU230784B1 (en)	2018-05-02
CY1114000T1 (el)	2016-07-27
EA004761B1 (ru)	2004-08-26
ZA9811127B (en)	2000-07-11
EP1417972B2 (en)	2018-08-22
IL136662A (en)	2004-09-27
SK288203B6 (sk)	2014-07-02
DK1417972T4 (en)	2018-10-22
ID27741A (id)	2001-04-26
MY120063A (en)	2005-08-30
JP4405666B2 (ja)	2010-01-27
HUP0004447A2 (hu)	2001-04-28
EP0920873A2 (en)	1999-06-09
BR9813463A (pt)	2000-10-10
CA2314313C (en)	2005-02-08
ES2215268T3 (es)	2004-10-01
ES2405994T5 (es)	2019-01-30
CN1198644C (zh)	2005-04-27
KR20010032881A (ko)	2001-04-25
KR100482703B1 (ko)	2005-04-14
ES2405994T3 (es)	2013-06-04

Legal Events

Date	Code	Title	Description
2019-01-14	MK1K	Patent expired

Publication	Publication Date	Title
DK1417972T3 (da)	2013-05-13	Stabiliserede teriparatidopløsninger
NO20003131D0 (no)	2000-06-16	Krystallinsk teriparatid
DE69826749D1 (de)	2004-11-11	Stabilisierte Persäurelösungen
ID22500A (id)	1999-10-21	Turunan sulfonamida
ID24430A (id)	2000-07-20	Turunan-turunan benzamidina
NO2006014I1 (no)	2006-11-13	Insulin glulisin
DE59804393D1 (de)	2002-07-18	Luftleiteinrichtung
FI973171A0 (fi)	1997-07-31	Foerfarande foer drift av arbetsfartyg
NO20002555L (no)	2000-07-14	Skjøt
DE69815673D1 (de)	2003-07-24	Stabilisierte hydroxylaminlösungen
IT1304161B1 (it)	2001-03-08	Stiratoio
ID20897A (id)	1999-03-25	Susunan penutup-rapat
FI973961A0 (fi)	1997-10-15	Lyft- och belastningsanordning foer en valsstapel i en kalander
DE69734891D1 (de)	2006-01-19	Ausrichtvorrichtung
FI972138A0 (fi)	1997-05-20	Returtraog i bestrykningsanordning
ID21138A (id)	1999-04-29	Teknologi film-tipis untuk head-drum
KR980001295U (ko)	1998-03-30	개량 도장
FI974242A0 (fi)	1997-11-14	Formframstaellning av plywoodprofil i kontinuerlig drift
BR7700789U (pt)	1998-12-22	Prumo
FI971123A0 (fi)	1997-03-18	Foervarings- och transportredskap i synnerhet foer pappersprodukter
FI971651A0 (fi)	1997-04-18	Spaormaskin i en elmaskin
FI974373A0 (fi)	1997-12-01	Avgasutlopp i utombordsmotorer
FI974354A0 (fi)	1997-11-27	Kvaevereducering i avloppsvatten
FI972997A0 (fi)	1997-07-15	Anordning i en sugsamlarvagn
FI972891A0 (fi)	1997-07-08	I en vaeggkonstruktion infaellbart faerdigt elkanalnaet